The Risk and Reversibility of Osimertinib-Related Cardiotoxicity in a Real-World Population.
Bak M, Park H, Lee SH, Lee N, Ahn MJ, Ahn JS, Jung HA, Park S, Cho J, Kim J, Park SJ, Chang SA, Lee SC, Park SW, Kim EK.
Bak M, et al. Among authors: chang sa.
J Thorac Oncol. 2024 Oct 10:S1556-0864(24)02377-3. doi: 10.1016/j.jtho.2024.10.003. Online ahead of print.
J Thorac Oncol. 2024.
PMID: 39395664